Karl Freemyer

Karl Freemyer currently serves as the Head of Business Development at FIECON, a company specializing in supporting the commercialization of innovative medical technologies. With previous experience at Genesis Research, Labcorp Drug Development, AstraZeneca, and DSM Nutritional Products, Karl has a strong background in life sciences consulting, market access, and commercial strategy. Karl holds a Bachelor of Arts in Economics from Rutgers University and is currently pursuing a Master of Business Administration in Pharmaceutical Management from Rutgers Business School.